Corium Reports Fiscal Year-End 2014 Financial Results and Recent Corporate Development
MENLO PARK, Calif., Nov. 17, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the fiscal…